One-Month Dual Antiplatelet Therapy in Patients With Chronic and Acute Coronary Syndromes Treated With Bioresorbable Polymer Everolimus-Eluting Stents.

MLA

Musto, Carmine, et al. “One-Month Dual Antiplatelet Therapy in Patients With Chronic and Acute Coronary Syndromes Treated With Bioresorbable Polymer Everolimus-Eluting Stents.” The American Journal of Cardiology, vol. 207, Nov. 2023, pp. 170–78. EBSCOhost, https://doi.org/10.1016/j.amjcard.2023.08.128.

APA

Musto, C., Paolucci, L., Pivato, C. A., Testa, L., Pacchioni, A., Briguori, C., Esposito, G., Piccolo, R., Lucisano, L., De Luca, L., Conrotto, F., Sanz-Sanchez, J., Cesario, V., De Felice, F., Latini, A. C., Regazzoli, D., Sardella, G., Indolfi, C., Reimers, B., … Stefanini, G. (2023). One-Month Dual Antiplatelet Therapy in Patients With Chronic and Acute Coronary Syndromes Treated With Bioresorbable Polymer Everolimus-Eluting Stents. The American Journal of Cardiology, 207, 170–178. https://doi.org/10.1016/j.amjcard.2023.08.128

Chicago

Musto, Carmine, Luca Paolucci, Carlo Andrea Pivato, Luca Testa, Andrea Pacchioni, Carlo Briguori, Giovanni Esposito, et al. 2023. “One-Month Dual Antiplatelet Therapy in Patients With Chronic and Acute Coronary Syndromes Treated With Bioresorbable Polymer Everolimus-Eluting Stents.” The American Journal of Cardiology 207 (November): 170–78. doi:10.1016/j.amjcard.2023.08.128.